Advanced Catheter Therapies
Advanced Catheter Therapies (ACT) develops innovative medical devices, notably the Pressana Occlusion Perfusion Catheter (OPC), which is used for targeted drug delivery in peripheral arterial disease treatment. The company focuses on R&D, licensing, and has received FDA clearances and patents. It aims to improve treatment control, safety, and efficacy for vascular conditions.
Industries
Nr. of Employees
small (1-50)
Advanced Catheter Therapies
Chattanooga, Tennessee, United States, North America
Products
Occlusion perfusion catheter for localized liquid therapy
A catheter system that creates an isolated arterial perfusion chamber using proximal and distal occlusion balloons and a center balloon to enable targeted infusion, controlled circulation and evacuation of liquid therapeutic agents with intrachamber pressure monitoring and radiopaque markers for imaging-guided placement.
Occlusion perfusion catheter for localized liquid therapy
A catheter system that creates an isolated arterial perfusion chamber using proximal and distal occlusion balloons and a center balloon to enable targeted infusion, controlled circulation and evacuation of liquid therapeutic agents with intrachamber pressure monitoring and radiopaque markers for imaging-guided placement.
Services
Technology licensing and distribution
Licensing of catheter-based liquid delivery technology and formation of distribution partnerships to commercialize the device.
Technology licensing and distribution
Licensing of catheter-based liquid delivery technology and formation of distribution partnerships to commercialize the device.
Expertise Areas
- Endovascular liquid drug delivery
- Peripheral arterial disease treatment (below-the-knee applications)
- Catheter-based device design and development
- Clinical evidence generation and peer-reviewed research
Key Technologies
- Occlusion balloon perfusion systems
- Isolated intravascular perfusion chambers
- Fiberoptic intravascular pressure sensing
- Radiopaque marker localization